Two Sigma Investments
NDRA icon

Two Sigma Investments’s ENDRA Life Sciences NDRA Stock Holding History

Two Sigma Investments’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-405
Closed -$2.85K – 3395
2024
Q3 		$2.85K Buy
+405
New +$31.4K ﹤0.01% 3072

Other funds holding NDRA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Two Sigma Investments's NDRA Position: Q4 2024 in Review

Two Sigma Investments sold out of ENDRA Life Sciences (NDRA) in Q4 2024, closing a stake of 405 shares — an estimated $2.85K sold.

Two Sigma Investments first reported a position in NDRA in Q3 2024 and held it in 1 quarter. The position peaked at $2.85K in Q3 2024. 4 funds tracked by Wall St. Rank hold NDRA as of Q4 2024.

  • Two Sigma Investments reported no remaining ENDRA Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 405 ENDRA Life Sciences shares in Q4 2024, an estimated $2.85K.
  • Two Sigma Investments first reported a position in ENDRA Life Sciences in Q3 2024 and held it in 1 quarter.
  • Two Sigma Investments's ENDRA Life Sciences position peaked at $2.85K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.